Introduction 48
Malaria is a mosquito-borne infectious disease caused by protozoan parasites of the 49 genus Plasmodium. Despite some progress in malaria control across the globe, 228 50 million cases still occurred worldwide in 2018, causing 405 000 deaths, mostly young 144 Of the preys, 165 were obtained at concentrations >1x10 7 LU/mL which we regarded as 145 potentially informative, of which 139 preys (including CD81, SR-BI, EphA2, and integrin 146 αvβ3) were obtained at >4x10 8 LU/mL which we regarded as optimal. Results of Western 147 blotting of preys are shown in Figure 2D and Supplementary Figure 2 . 148 To provide additional assurance regarding the quality of key bait and prey proteins, and 149 in particular the activity of the folded proteins in a plate-format assay, we tested whether 150 the full-length CSP bait, and CD81, SR-BI and EphA2 preys could be captured onto 96 well 151 plate using cognate monoclonal antibodies. Captured baits and preys were detected using 152 ELISA and luciferase assay respectively, demonstrating the expected antibody reactivity Having developed the modified high-throughput AVEXIS method and constructed the prey, and then for noise attributable to the bait (see Methods). Raw, prey-corrected and 161 final results are shown on separate worksheets in Supplementary Table 3 . 162 All 16016 possible sporozoite protein/hepatocyte protein pairs were tested 163 ( Supplementary Table 3 ). Of these, 7540 candidate interactions were tested using protein 164 concentrations we would regard as optimal (bait concentration ≥7 nM, prey 165 concentration 4x10 8 LU/mL, and good protein quality as assessed by Western blotting), 166 and a further 4718 were tested using protein concentrations which our assay validation 167 data ( Fig 1C) suggested would provide a signal:noise ratio of >10 for any of our 'test set' 168 of four known interactions. 169 Across the tested interactions, the highest signal:noise ratio (198) were obtained in a similar screen investigating P. berghei [26] .
197
To confirm the Pf34-FGFR4 interaction, the AVEXIS assay was repeated using 198 reciprocally-oriented constructs, with FGFR4 expressed as dimeric bait and probed with 199 pentameric Pf34 prey. Again, clear and reproducible binding was observed ( Fig 2B) . Having identified the interaction between human FGFR4 and P. falciparum Pf34, we 211 examined whether this interaction is conserved across species by testing murine FGFR4 212 for interaction with the Pf34 orthologs found in the rodent malaria parasites P. yoelii and 213 P. berghei. We found no evidence of interaction of either of these protein pairs, despite 214 expression of all proteins at levels in the range expected to give optimal AVEXIS 215 sensitivity ( Figure 3E ).
216
Pairwise host-pathogen protein-protein interactions are frequently components of larger 217 multi-molecular complexes, and so we proceeded to investigate possible additional 218 interacting partners of Pf34.
219
Binding of many FGF family members to their receptors is enhanced by heparin and/or 220 heparan sulfate [27] . Using SPR, we tested whether heparin and heparan sulphate (HS) 221 may have a similar affect upon the Pf34 -FGFR4 interaction. We used a similar design to 222 that used in our experiment measuring Pf34 -FGFR4 kinetics, assessing whether pre-Discussion 227 Invasion of hepatocytes by P. falciparum. sporozoites is a bottleneck in the malaria 228 parasite lifecycle. Inhibition of this process, particularly by vaccine-induced antibodies, 229 is a major focus in efforts to develop means of malaria prevention. This effort is hindered 230 by limited knowledge of the host-parasite interactions involved in hepatocyte invasion.
231
This study has therefore sought to improve understanding in this area.
232
Our approach, expressing human and P. falciparum proteins in a human cell line and 233 testing them for interaction using a modified AVEXIS assay, was designed to achieve the 234 best sensitivity which we could achieve in a broad, high-throughput screen. Our selection We found no evidence of interactions with sporozoite proteins of the previously reported 253 host receptors for sporozoite invasion (CD81, SR-BI, EphA2), nor of interactions with host 254 proteins of the suspected sporozoite invasion ligands P36 and P52. The role of these 255 proteins in the invasion process remains incompletely understood.
256
Our key novel findings are the interactions of Pf34 with the host protein FGFR4 and 257 PIESP15 with LDLR. The interaction of Pf34 with FGFR4 is of very low affinity, but in the 258 context of apposed membranes weak monovalent interactions can sum to provide 259 significant avidity and to become biologically critical (as illustrated by the Juno-Izumo 260 interaction which is essential for mammalian fertilisation [17]). It is also possible that the 261 Pf34 -FGFR4 interaction occurs in the context of a multi-molecular complex which 262 provides higher affinity between the host and parasite members. This possibility is 263 supported by the fact that a co-receptor, β-klotho, contributes substantially to the binding 264 affinity of FGFR4's endogenous ligands [28] . We were unfortunately unable to express β-265 klotho in sufficient quantities to further explore this possibility. 266 The possibility that interactions between Pf34 and FGFR4 could contribute to a to asparagine-X-alanine. Genes were then codon optimised for mammalian expression.
313
For three of the very large proteins from the cysteine-rich modular protein family 314 (CRMP1, 3 and 4), we designed two to three constructs, together spanning the 315 ectodomain. Given the importance of CSP and its known domain architecture, we 316 designed both a full-length construct and N-terminal and C-terminal domain constructs.
317
The remaining coding sequences were synthesized by Twist Biosciences or, for large or 318 challenging genes, ThermoFisher. interpolating from a standard curve of samples of known protein concentration (Fig 2A) . 396 For use in AVEXIS screening, bait concentration was adjusted to a target of 7 nM by 397 dilution with Blocker casein (ThermoFisher) or concentration using a 30kDa MWCO 398 Vivaspin centrifugal filter.
399
Preys were expressed as soluble 5×NanoLuc tagged proteins. Prey levels were quantified 400 in supernatants using the Nano-Glo Luciferase Assay System according to the 401 manufacturer's instructions (Promega), with the exception that the substrate solution 402 was diluted 1 in 20 in PBS prior to use. 50 µL of supernatant diluted 1:10,000 with casein 403 was mixed with 50 µL of NanoLuc substrate in a well of 96-well white Maxisorp plate 404 (VWR) and incubated for 3 min at room temperature. Plates were transferred to the 405 Clariostar plate reader and luminescence units (LU) measured ( Fig 2B) . 406 All preys were then diluted with 1 volume of Blocker casein (a step which we have found 407 reduces background noise [data not shown]) or, in the case of proteins at ≥8x10 8 LU/mL, 408 adjusted to a target of 4x10 8 LU/mL by dilution with Blocker casein. Given that integrin 409 constructs were of particular interest and these preys expressed at relatively low levels, Chemiluminescent substrate (ThermoFisher) (Fig 2C-D) . was removed and normalised baits were immobilised onto the plates overnight at 4ᴼC.
443
The next day, plates were washed as above, and normalised preys were added and 444 incubated for 2h at room temperature. Plates were washed and bound preys were 445 detected by using the Nano-Glo Luciferase Assay System (as described for prey 446 quantification).
447
Given that background levels of signal were observed to vary between preys, the screen 448 was performed by testing one prey against all baits on a single plate. Each plate included 449 the following controls: a 'pulldown' of the prey being investigated using anti-FLAG 450 antibody (Sigma Aldrich, Cat. No. F1804), to confirm the addition of functional prey; 451 positive control interaction using P. falciparum RH5 as bait and human BSG as prey; and 452 a negative control interaction using irrelevant bait and human BSG as prey.
453
AVEXIS results are presented in terms of signal:noise ratios, to correct for varying levels 454 of non-specific luminescence attributable to different constructs. The major determinant 455 of the level of noise is the prey (background luminescence after application to wells 456 coated with irrelevant baits varies 10-fold or more between different preys). In the case 457 of experiments using small numbers of baits and preys (<10 in total), signal:noise ratios 458 were thus calculated simply by dividing by the result obtained in wells containing an 459 irrelevant bait and probed with the prey of interest. In the case of the high-throughput 460 screen, we initially performed a 'single correction', dividing luminescence by the median 461 result across all baits probed with the prey in question (i.e. the median result on the 462 plate). The use of the median as 'noise' is based upon the assumption that the vast 463 majority of protein pairs will not interact, and hence the median bait can be regarded as 464 a more representative irrelevant control than any single bait picked to act as a control. A 465 small number of baits appeared to bind non-specifically to multiple preys. We therefore 466 performed 'double correction', dividing the 'single corrected' result for a given 467 interaction by the median 'single corrected' result for all preys tested with the same bait 468 to produce a final signal:noise ratio.
469
The screen was performed in singlicate. All apparent novel interactions with signal:noise 470 ratios exceeding 30 were repeated, as described in Supplementary Table 4 , initially using 471 the same protein preparations. Interactions which were not reproduced were assumed 472 to have been falsely positive in the initial screen, probably due to incomplete plate 473 washing.
474
Interaction blocking experiments were performed similarly, with the exception that 475 blocking reagents (antibodies) were added onto the immobilised baits on the plate for 1h 476 prior to addition of preys. Increasing concentrations of the purified FGFR4 analyte were injected at 30 µL/min over 491 the chip surface, each for 60s followed by a 120s dissociation phase. The Biacore single-492 cycle kinetics mode (without regeneration between injections) was used, although due to 493 the rapid kinetics of the interaction, all previously bound protein was dissociated prior 494 to the start of each injection.
495
Data was analysed using Biacore T200 evaluation software (GE Healthcare). All data was 496 double-reference subtracted before model fitting (i.e. both the signal on the reference 497 flow cell with the same analyte and the signal detected during a buffer-only blank 498 injection were subtracted from the signal with the analyte on the active flow cell). 1:1 499 binding models were fitted to both kinetic data and equilibrium binding data.
500
Heparin and Heparan sulfate (Sigma) were resuspended in HBS-EP+ buffer and used for 501 surface plasmon resonance studies at 1 mg/mL. Supplementary Table S1 . Sporozoite protein ectodomain library details 593 Details include bait index number (corresponding to numbering in Figure 3A ), construct 594 boundaries and sequence, and expression levels (corresponding to Figure 2A ). 595 596 Supplementary Table S2 . Human hepatocyte protein ectodomain library details.
Figure Legends

597
Details include construct boundaries and sequence, and expression levels (corresponding 598 to Figure 2B ). Integrin α and β chain constructs are listed on the second worksheet, and 599 the results of integrin heterodimer expression are listed on the third worksheet. Supplementary Table S3 .
602
First worksheet presents complete AVEXIS screen results, presented in terms of double-603 corrected signal:noise ratio (see Methods). Color scale denotes the signal:noise ratio of 604 each interaction, ranging from dark green (low) through yellow to dark red (high).
605
Second and third worksheets show results with FGFR4 prey against all sporozoite baits 606 (as shown in Figure 3A ) and with Pf34 prey against all sporozoite baits (as shown in 607 Figure 4B ). 608 609 Supplementary Table S4 .
610
All protein pairs with a signal:noise ratio exceeding 5 in the initial AVEXIS screen. 
